Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Leuk Res ; 116: 106836, 2022 05.
Article in English | MEDLINE | ID: mdl-35405632

ABSTRACT

BACKGROUND: Azacitidine (AZA) is approved for the treatment of high-risk chronic myelomonocytic leukemia (CMML) of myelodysplastic (MD) subtype. Data of response rates using the specific response criteria for this disease are scarce. The aim of this study was to evaluate the response to AZA in patients diagnosed with CMML from the Spanish Registry of Myelodysplastic Syndromes (MDS) applying the overlap myelodysplastic/myeloproliferative neoplasms (MDS/MPN) response criteria. METHODS: We retrospectively studied 91 patients with CMML treated with at least one cycle of AZA from the Spanish Registry of MDS. As it was a real-world study, the response rate was evaluated between cycle 4 and 6, applying the MDS/MPN response criteria FINDINGS: The overall response rate at cycle 4-6 was 58%. Almost half of the patients achieved transfusion independence and one quarter showed clinical benefit, regardless of the CMML French-American-British (FAB) and World Health Organization (WHO) subtypes and CMML Specific Prognosis Scoring (CPSS) risk groups. Toxicity was higher in the MD-CMML subtype. INTERPRETATION: In our series, most CMML patients achieved an overall response rate with AZA according to the overlap-MDS/MPN response criteria regardless of the CMML FAB and WHO subtypes and CPSS risk groups. Thus, AZA may also be a treatment option for patients with the myeloproliferative CMML subtype and those with a lower-risk CPSS, but symptomatic.


Subject(s)
Azacitidine , Leukemia, Myelomonocytic, Chronic , Azacitidine/adverse effects , Azacitidine/therapeutic use , Humans , Leukemia, Myelomonocytic, Chronic/drug therapy , Myelodysplastic Syndromes/diagnosis , Myelodysplastic Syndromes/drug therapy , Myelodysplastic-Myeloproliferative Diseases/drug therapy , Retrospective Studies
2.
ACS Appl Mater Interfaces ; 11(34): 31499-31507, 2019 Aug 28.
Article in English | MEDLINE | ID: mdl-31368697

ABSTRACT

Efficient separation and storage of gas streams involving light hydrocarbons is essential for industrial applications. These hydrocarbons are widely used as energy resources and/or chemical raw materials in various chemical reactions. Here, we focus on the separation of acetylene from methane and carbon dioxide. The separation of acetylene from carbon dioxide is, in particular, challenging due to the similar kinetic diameters and boiling points of the molecules. In recent years, considerable progress has been made in adsorption-based separations using porous metal-organic frameworks (MOFs). Most reported studies are experimental. We present a computational study on these gas separations using a variety of MOFs. This allows investigation of the competitive gas adsorption, which is experimentally challenging, as well as understanding the adsorption mechanisms at the molecular level, which in turn allows further experimental MOF design for this application. MOFs with open metal sites, and particularly Fe-MOF-74, seem to be good for this separation, with a trade-off between physical adsorption capacity and selectivity. Based on experimental single-adsorption isotherms at various temperatures, we developed and validated a specific parameterization to account for the interactions of the olefin with the open metal sites. In addition to volumetric and calorimetric adsorption, we comprehensively investigate the characteristics of the interaction between the MOFs and the guest molecules in terms of binding sites and density profiles. The overall agreement of our simulated results with experimental data for pure components points to the reliability of the models and methods to successfully predict the separation of mixtures.

3.
ACS Appl Mater Interfaces ; 10(19): 16911-16917, 2018 May 16.
Article in English | MEDLINE | ID: mdl-29671568

ABSTRACT

The separation and purification of light hydrocarbons is challenging in the industry. Recently, a ZJNU-30 metal-organic framework (MOF) has been found to have the potential for adsorption-based separation of olefins and diolefins with four carbon atoms [H. M. Liu et al. Chem.-Eur. J. 2016, 22, 14988-14997]. Our study corroborates this finding but reveals Fe-MOF-74 as a more efficient candidate for the separation because of the open metal sites. We performed adsorption-based separation, transient breakthrough curves, and density functional theory calculations. This combination of techniques provides an extensive understanding of the studied system. Using this MOF, we propose a separation scheme to obtain a high-purity product.

5.
Phys Chem Chem Phys ; 19(7): 5037-5042, 2017 Feb 15.
Article in English | MEDLINE | ID: mdl-28165090

ABSTRACT

The product of catalytic isomerization is a mixture of linear and branched hydrocarbons that are in thermodynamic equilibrium, and their separation becomes necessary in the petrochemical industry. Zeolite 5A is usually industrially used to sieve alkane isomers, but its pore size allows only the separation of linear alkanes from the monobranched and dibranched alkanes by a kinetic mechanism. A more efficient approach to improve the average research octane number would be to adsorptively separate the di-methyl alkanes as products and recycle both the linear and mono-methyl alkanes to the isomerization reactor. Since the microscopic processes of adsorbates in zeolites are generally difficult or impossible to determine by experiments, especially in the case of mixtures, molecular simulation represents an attractive alternative. In this computational study, we propose a conceptual separation process for hexane isomers consisting of several adsorptive steps. Different zeolite topologies were examined for their ability to conduct this separation based on adsorption equilibrium and kinetics.

6.
J Nutr ; 129(5): 928-33, 1999 May.
Article in English | MEDLINE | ID: mdl-10222381

ABSTRACT

Liver gamma-cystathionase activity increases in rats during lactation; its inhibition due to propargylglycine is followed by a significant decrease in lactation. This is reversible by N-acetylcysteine administration. To study the role of liver gamma-cystathionase and the intertissue flux of glutathione during lactation, we used lactating and virgin rats fed liquid diets. Virgin rats were divided into two groups as follows: one group was fed daily a diet containing the same amount of protein that was consumed the previous day by lactating rats (high protein diet-fed rats); the other virgin group was fed the normal liquid diet (control). The expression and activity of liver gamma-cystathionase were significantly greater in lactating rats and in high protein diet-fed virgin rats compared with control rats. The total glutathione [reduced glutathione (GSH) + oxidized glutathione (GSSG)] released per gram of liver did not differ in lactating rats or in high protein diet-fed rats, but it was significantly higher in these two groups than in control virgin rats. Liver size and the GSH + GSSG released by total liver were significantly higher in lactating rats than in high protein diet-fed virgin rats, and this difference was similar to the amount of glutathione taken up by the mammary gland (454.2 +/- 36.0 nmol/min). The uptake of total glutathione by the lactating mammary gland was much higher than the uptakes of free L-cysteine and L-cystine, which were negligible. These data suggest that the intertissue flux of glutathione is an important mechanism of L-cysteine delivery to the lactating mammary gland, which lacks gamma-cystathionase activity. This emphasizes the physiologic importance of the increased expression and activity of liver gamma-cystathionase during lactation.


Subject(s)
Cystathionine gamma-Lyase/metabolism , Lactation/physiology , Liver/enzymology , Acetylcysteine/pharmacology , Alkynes/pharmacology , Amino Acids/analysis , Animals , Cysteine/metabolism , Cystine/metabolism , Dietary Proteins/administration & dosage , Enzyme Inhibitors/pharmacology , Female , Glutathione/analysis , Glutathione/metabolism , Glycine/analogs & derivatives , Glycine/pharmacology , Mammary Glands, Animal/metabolism , Milk/chemistry , Oxidation-Reduction , Rats , Rats, Wistar
7.
Br J Nutr ; 78(5): 823-31, 1997 Nov.
Article in English | MEDLINE | ID: mdl-9389904

ABSTRACT

To study the fate of L-cysteine and amino acid homeostasis in liver after the inhibition of the trans-sulfuration pathway, rats were treated with propargylglycine (PPG). At 4 h after the administration of PPG, liver cystathionase (EC 4.4.1.1) activity was undetectable, L-cystathionine levels were significantly higher, L-cysteine was unchanged and GSH concentration was significantly lower than values found in livers from control rats injected intraperitoneally with 0.15 M-NaCl. The hepatic levels of amino acids that are intermediates of the urea cycle, L-ornithine, L-citrulline and L-arginine and blood urea were significantly greater. Ura excretion was also higher in PPG-treated rats when compared with control rats. These data suggest a stimulation of ureagenesis in PPG-treated rats. The inhibition of gamma-cystathionase was reflected in the blood levels of amino acids, because the L-methionine: L-cyst(e)ine ratio was significantly higher in PPG-treated rats than in control rats; blood concentration of cystathionine was also greater. Histological examination of liver and kidney showed no changes in PPG-treated rats when compared with controls. The administration of N-acetylcysteine (NAC) to PPG-treated rats reversed the changes in blood urea and in liver GSH. These data suggest that when liver L-cysteine production was impaired by the blockage of the trans-sulfuration pathway, the concentration of this amino acid was maintained mainly by an increase in protein degradation and by a depletion in GSH concentration that may spare L-cysteine.


Subject(s)
Alkynes/pharmacology , Cystathionine gamma-Lyase/antagonists & inhibitors , Cystathionine/metabolism , Cysteine/metabolism , Glutathione/metabolism , Glycine/analogs & derivatives , Liver/metabolism , Acetylcysteine/pharmacology , Animals , Cystathionine/blood , Cysteine/blood , Depression, Chemical , Glycine/pharmacology , Male , Methionine/blood , Rats , Rats, Wistar , Urea/urine
SELECTION OF CITATIONS
SEARCH DETAIL
...